Financials • Specialty Insurers
$2.05 ▼ -0.16
(-7.24%)
MKT CAP: $3.7M • VOL: 25.1K
52W L $2 52W H $40
ROARABLE / RQD
E • 26/100
PIOTROSKI
3 / 9
EZRA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $12.4M | $14.1M | $13.7M |
| YoY Revenue Growth % | -11.6% | +2.3% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$9.0M | -$7.7M | -$13.9M |
| Operating Margin % | -72.5% | -54.8% | -80.0% |
| Net Income (GAAP) | -$7.0M | -$9.1M | -$12.0M |
| EBITDA (Normalized) | -$9.0M | -$7.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$3.1M | -$2.5M | -$848.0K |
| Capital Expenditures (CapEx) | $15.9K | $24.3K | — |
| Free Cash Flow (FCF) | -$3.1M | -$2.5M | -$848.0K |
| FCF Margin % | -25.0% | -18.1% | -6.2% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $4.1M | $9.5M | — |
| Total Stockholders' Equity | $6.4M | $3.0M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR EZRA.